Latest News about NVO
Recent news which mentions NVO
From InvestorPlace
Facebook News To Shut Down In Europe, Warner Bros. Discovery Revises Outlook As Strike Bites, Manchester United No Longer Up For Sale: Today's Top Stories
September 05, 2023
From Benzinga
Novo Nordisk's Weight Loss Drug Wegovy In Short Supply, Yet Goes Ahead With UK Launch
September 05, 2023
Tickers
NVO
From Benzinga
Stocks and bonds are out of balance. Here’s what could come next.
September 05, 2023
From MarketWatch
China Rallies, Europe Dips: US Market Outlook For Labor Day-Shortened Week
September 04, 2023
From Benzinga
Ozempic Maker Beats Bernard Arnault's LVMH As Europe's Most Valuable Firm With Stunning $423B Market Cap
September 04, 2023
From Benzinga
Could CVS Make a Copy of Ozempic?
September 02, 2023
From Motley Fool
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
From Motley Fool
The 3 Most Promising Healthcare Stocks to Own Now
September 01, 2023
From InvestorPlace
From Benzinga
3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy
September 01, 2023
From Motley Fool
Novo Nordisk Continues Pursuit Of Obesity-Targeted Companies: Second Acquisition Within A Month
August 30, 2023
From Benzinga
From Motley Fool
From MarketWatch
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
August 29, 2023
From Benzinga
Tickers
NVO
From Motley Fool
From Benzinga
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
August 29, 2023
From Benzinga
Why Wegovy's Sales Potential Could Be Massively Understated
August 29, 2023
From Motley Fool
3 Emerging Market Stocks to Buy in August
August 28, 2023
From InvestorPlace
Novo Nordisk's Popular Weight Loss Drug Wegovy Might Be Heavy On Denmark's Healthcare System
August 28, 2023
Tickers
NVO
From Benzinga
3 Top Growth Stocks I'd Buy Right Now Without Hesitation
August 28, 2023
From Motley Fool
From Motley Fool
Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles
August 25, 2023
From Benzinga
From Benzinga
Novo Nordisk's Weight Loss Treatment Shows Benefit In Patients With Most Common Type Of Heart Failure
August 25, 2023
Tickers
NVO
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.